Earnings Releases·Oct 30, 2026, 6:49 AM ET

Kenvue — Third Quarter 2026 Earnings Summary

Net sales rose 3.2% year-over-year to $3.886 billion, driven by 2.9% organic growth, while diluted EPS increased 5% to $0.22 and adjusted diluted EPS rose 4% to $0.29.
Operating income margin expanded to 18.2% (from 16.7%) and adjusted operating income margin reached 21.9% (from 21.5%), supported by strong performance in Self Care (5.9% sales growth) and Essential Health (2.5% sales growth).
Free cash flow for the nine-month period increased to $1.6 billion from $1.0 billion, and total debt decreased to $8.2 billion from $8.5 billion as of December 28, 2025.
The company will not provide forward-looking guidance due to the pending transaction with Kimberly-Clark, and no quarterly conference call will be hosted.
The 2026 Restructuring Initiative incurred $41 million in expenses for the quarter, with total expected pre-tax charges for the fiscal year estimated at approximately $250 million.